This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

FSH/LH levels

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Ovarian failure is indicated by consistently raised FSH levels - over 30IU/l - together with raised LH and low serum oestradiol levels (1).

If a woman has symptoms typical of the menopause and has a slightly irregular menstrual cycle, then a raised FSH in the early follicular phase may indicate the perimenopause, and it is likely that the patient will become menopausal during the next five years.

NICE state (2):

  • FSH test:
    • do not use a serum follicle-stimulating hormone (FSH) test to diagnose menopause in women using combined oestrogen and progestogen contraception or high-dose progestogen

    • consider using a FSH test to diagnose menopause only:
      • in women aged 40 to 45 years with menopausal symptoms, including a change in their menstrual cycle

      • in women aged under 40 years in whom menopause is suspected

        • diagnose premature ovarian insufficiency in women aged under 40 years based on:
          • menopausal symptoms, including no or infrequent periods (taking into account whether the woman has a uterus) and
          • elevated FSH levels on 2 blood samples taken 4-6 weeks apart

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.